Nascent Biotech Investor Relations

Nascent Biotech is building a portfolio of innovative therapeutic antibodies, poised at various stages of development, ranging from laboratory to the eve of preclinical trials.

Nascent Biotech, Inc. is a biotechnology company developing proprietary human Monoclonal Antibodies (mAbs) and immunotherapy for treatment of cancer.

Our development strategy involves pursuing a novel target not being explored by other companies; developing broad pipeline including therapies and diagnostics against the antigen, and platform drug delivery technology.

Our lead therapeutic asset, Pritumumab, has been validated in 249 human brain cancer patients.

Nascent Biotech is a publicly traded company (OTC: NBIO).

Some of our achieved milestones include:

  • Re-engineered antibody into CHO cells; created and fully characterized Master Cell Bank (MCB) in accord with FDA requirements
  • Developed scale-up CGMP-compliant manufacturing process; production of material for human clinical trials
  • Presented new clinical plan to FDA in pre-IND (Investigational New Drug) meeting
  • Initiated toxicology studies
  • Secured NIH funding for novel “second generation” platform in collaboration with MAPP Biopharma
  • Granted Orphan Drug Designation
Nascent Biotech Inc. [NBIO: OTCQB]
0.20 -0.02 (-9.09%)  12/14/2018 Delayed 15 minutes 
Open$0.25Daily Range$0.20-$0.30
Prev. Close$0.2252 Week Range$0.10-$0.77
Volume42,282  
Quote Data   Realtime
Inside Quote
BidAskLast Inside Change
$0.20 x 10000 shares$0.21 x 2500 shares12/14 5:00 PM EST
Level II Quote Montage
BID
ASK
MMIDBid PriceBid SizeDate/Time
NITE0.20500012/14
CDEL0.20500012/14
VNDM0.051000012/13
PUMA0.011000011/12
BGCE0.00011000009/04
MAXM0.00011000012/14
CSTI0.00011000012/14
CANT0.00011000012/14
ETRFU12/14
OTCXU12/14
MMIDAsk PriceAsk SizeDate/Time
CANT0.21250012/14
PUMA0.325250012/12
CDEL0.351200012/14
NITE0.375250012/10
MAXM0.59100012/14
VNDM0.63100012/13
CSTI0.69100012/14
OTCX0.70390012/14
BGCE0.70100009/04
ETRFU12/14

The quotes displayed here are published by market makers on the OTC Markets Group Inc. electronic inter-dealer quotation and trading system for OTC securities. Please see Terms of Service and Risk Warning for more information.

MMID - Market maker quotation published in OTC Link that meets the Inside market | MMID - Market maker quotation published in OTC Link | cMMID - Closed quote | Unpriced - Unpriced quote in OTC Link | MMIDu - Unsolicited market maker quotation published in OTC Link